Log in to search using one of your social media accounts:

 

S.C. Officials Indicted for Exposing Firemen to Asbestos
The Marion, South Carolina, city administrator and its fire chief have been indicted on charges of knowingly exposing staff, volunteer workers and community members to toxic asbestos. Both were granted a personal recognizance bond at their arraignment Nov. 17 in the Marion County Courthouse. City Administrator Alan Thomas Ammons and Fire Chief Ralph Walton Cooper III were charged with misconduct in office, conspiracy to violate the Pollution Control Act, and violation of the Pollution Control Act. All three indictments — signed by South Carolina Attorney General Alan Wilson — were filed Nov. 2, 2017. The alleg...
Source: Asbestos and Mesothelioma News - November 22, 2017 Category: Environmental Health Authors: Daniel King Tags: Alan Thomas Ammons Alan Wilson asbestos exposure Ashley Brady Marion Fire Station Pollution Control Act Ralph Walton Cooper South Carolina Department of Health and Environmental Control Source Type: news

Lung cancer triggers pulmonary hypertension
(Max-Planck-Gesellschaft) Nearly half of all advanced-stage lung cancer patients develop arterial pulmonary hypertension. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 22, 2017 Category: Cancer & Oncology Source Type: news

Encouraging oxygen's assault on iron may offer new way to kill lung cancer cells
(NYU Langone Health / NYU School of Medicine) Blocking the action of a key protein frees oxygen to damage iron-dependent proteins in lung and breast cancer cells, making them easier to kill. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 22, 2017 Category: Cancer & Oncology Source Type: news

Is Lung Cancer Incidence in Never-Smokers Increasing? Is Lung Cancer Incidence in Never-Smokers Increasing?
Australian researchers report finding that lung cancer rates among never-smokers are stable, after US researchers raised the alarm over an apparent doubling in incidence.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 21, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

UN Agency Defers Action Cutting Ties to Tobacco Industry
Close-up of a woman hands hold and broke a cigarette. Credit: BigstockBy Thalif DeenUNITED NATIONS, Nov 21 2017 (IPS)Back in November 2008, the 193-member General Assembly decided, by consensus, to ban smoking and tobacco sales at the UN headquarters in New York: a ruling observed by all affiliated agencies worldwide, including the Geneva-based World Health Organization (WHO) which has severed links with the tobacco industry. But there still remains one holdout: the 187-member International Labour Organization (ILO) in Geneva whose Governing Body, which meets three times a year, has postponed once again its decision on whe...
Source: IPS Inter Press Service - Health - November 21, 2017 Category: International Medicine & Public Health Authors: Thalif Deen Tags: Development & Aid Global Headlines Health Poverty & SDGs TerraViva United Nations Source Type: news

Mobile scan cancer tests to be rolled out across England
Plans unveiled for more sensitive bowel cancer test Related items fromOnMedica Lung cancer blood test Lung experts call for ‘national plan for lung cancer’ Long delay after FIT linked to higher risk of cancer Screening for colorectal cancer should start at 45 years Developing and using a tool to improve outcomes in colorectal cancer (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 21, 2017 Category: UK Health Source Type: news

High survival rates in record number of lung cancer operations
5% rise in lung cancer operations, audit shows Related items fromOnMedica Major boost for lung cancer diagnosis Survival rates rise for lung cancer surgery Lung cancer blood test Lung experts call for ‘national plan for lung cancer’ UK lung cancer survival rates are improving (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 21, 2017 Category: UK Health Source Type: news

Papers of note in Science Translational Medicine 9 (416)
This week’s articles describe why pulmonary hypertension often arises with lung cancer; a way to interrupt the autoimmune response in type 1 diabetes; and a marker through which to screen patients for response to MSC therapy and risk for graft-versus-host disease. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - November 21, 2017 Category: Science Authors: Ferrarelli, L. K. Tags: STKE Editors ' Choice Source Type: news

NHS England action to save lives by catching more cancers early
NHS England has announced a scheme that catches lung cancer early by scanning patients, along with new details of a more sensitive bowel cancer test that could save thousands of lives. (Source: NHS Networks)
Source: NHS Networks - November 21, 2017 Category: UK Health Source Type: news

French Oncologists Upgrade Mesothelioma Standard of Care
Oncologists throughout France have joined the U.S.-based National Comprehensive Cancer Network (NCCN) in upgrading their recommended standard-of-care treatment regimen for unresectable pleural mesothelioma. Both groups have added bevacizumab (Avastin) to the traditional cisplatin and pemetrexed chemotherapy combination, expecting to see longer patient survival. “This is a major advancement for the care of mesothelioma patients,” Dr. Gerard Zalcman, head of thoracic oncology at Bichat-Claude Bernard Hospital, told Asbestos.com. “Clearly, this drug can change the natural history of this tumor.” Bevaci...
Source: Asbestos and Mesothelioma News - November 20, 2017 Category: Environmental Health Authors: Daniel King Tags: American Society of Clinical Oncology Avastin bevacizumab Bichat-Claude Bernard Hospital French Cooperative Thoracic Intergroup Gerard Zalcman National Comprehensive Cancer Network nintedanib Ofev pleural mesothelioma chemotherapy Source Type: news

Roche Cancer Drug Rises To Challenge Merck, Bristol-Myers
Tecentriq, a cancer immunotherapy developed by the Swiss drug giant Roche, slowed the progression of previously untreated lung cancer in a large clinical trial when combined with a chemotherapy regimen, the drug giant said. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 20, 2017 Category: Pharmaceuticals Authors: Matthew Herper, Forbes Staff Tags: OTC:RHHBY NYSE:MRK NYSE:BMY NYSE:AZN Source Type: news

Roche announces trial successes in cancer, haemophilia
ZURICH (Reuters) - Roche announced a double dose of trial wins on Monday, saying its immunotherapy Tecentriq mixed with other drugs made advances against lung cancer, while data suggested its haemophilia agent Hemlibra could be used by more patients. (Source: Reuters: Health)
Source: Reuters: Health - November 20, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Roche says Tecentriq combination cuts lung cancer risk
ZURICH (Reuters) - A late-stage trial of Roche's immuno-oncology medicine Tecentriq with other cancer drugs as an initial therapy for lung cancer met its goal of significantly reducing the risk of disease worsening or death, the Swiss drugmaker said on Monday. (Source: Reuters: Health)
Source: Reuters: Health - November 20, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Phase III IMpower150 study showed Roche ’s TECENTRIQ (atezolizumab) and Avastin (bevacizumab) plus chemotherapy significantly reduced the risk of disease worsening or death in the initial treatment of people with a type of advanced lung cancer
Roche today announced that the Phase III IMpower150 study met its co-primary endpoint of progression-free survival (PFS) and demonstrated that the combination of TECENTRIQ ® (atezolizumab) and Avastin® (bevacizumab) plus chemotherapy (paclitaxel and carboplatin) provided a statistically significant and clinically meaningful reduction in the risk of disease worsening or death (PFS) compared to Avastin plus chemotherapy in the first-line treatment of people with advan ced non-squamous non-small cell lung cancer (NSCLC). Initial observations for the co-primary endpoint of overall survival (OS) are encouraging. These d...
Source: Roche Media News - November 20, 2017 Category: Pharmaceuticals Source Type: news

Phase III IMpower150 study showed Roche ’s TECENTRIQ (atezolizumab) and Avastin (bevacizumab) plus chemotherapy significantly reduced the risk of disease worsening or death in the initial treatment of people with a type of advanced lung cancer
Roche today announced that the Phase III IMpower150 study met its co-primary endpoint of progression-free survival (PFS) and demonstrated that the combination of TECENTRIQ ® (atezolizumab) and Avastin® (bevacizumab) plus chemotherapy (paclitaxel and carboplatin) provided a statistically significant and clinically meaningful reduction in the risk of disease worsening or death (PFS) compared to Avastin plus chemotherapy in the first-line treatment of people with advan ced non-squamous non-small cell lung cancer (NSCLC). Initial observations for the co-primary endpoint of overall survival (OS) are encouraging. These d...
Source: Roche Investor Update - November 20, 2017 Category: Pharmaceuticals Source Type: news

Osimertinib improves progression-free survival in Asian EGFR-mutated lung cancer patients
(European Society for Medical Oncology) Osimertinib improves progression-free survival compared to standard first line therapy in Asian patients with EGFR-mutated non-small-cell lung cancer (NSCLC), according to the Asian subset analysis of the FLAURA trial presented at the ESMO Asia 2017 Congress, sumultaneously published in The New England Journal of Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 20, 2017 Category: Cancer & Oncology Source Type: news

Erlotinib Overdose Tied to Conjunctivitis
Findings in case study of man being treated for non - small - cell lung cancer (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 17, 2017 Category: Cancer & Oncology Tags: Family Medicine, Internal Medicine, Emergency Medicine, Oncology, Ophthalmology, Pharmacy, Journal, Source Type: news

Can AI diagnose pneumonia better than radiologists?
An artificial intelligence (AI) algorithm developed by Stanford University...Read more on AuntMinnie.comRelated Reading: Deep learning shows promise for bone age assessment Chest doctors issue guidelines for CT lung cancer screening AI algorithm predicts lung disease, adverse events on CT NIH opens massive x-ray database to propel AI research NIH releases massive database of chest x-rays (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 17, 2017 Category: Radiology Source Type: news

Lung Cancer
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - November 17, 2017 Category: General Medicine Source Type: news

ALEX study shows alectinib 600 mg more effective than crizotinib in Asian cancer patients
(European Society for Medical Oncology) A subanalysis of the phase III ALEX study has shown that alectinib 600 mg twice daily is more effective than standard of care crizotinib in Asian patients with anaplastic lymphoma kinase (ALK) positive non-small-cell lung cancer (NSCLC), researchers report at the ESMO Asia 2017 Congress. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 17, 2017 Category: Cancer & Oncology Source Type: news

Study analyzes mutations in cerebrospinal fluid in lung cancer with brain metastases
(European Society for Medical Oncology) Researchers have explored the analysis of mutations in cerebrospinal fluid of lung cancer patients with brain metastases in a study presented at the ESMO Asia 2017 Congress. Tumor tissue from brain metastasis is difficult to obtain and therefore less invasive methods are needed to identify and monitor the presence of known actionable mutations. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 17, 2017 Category: Cancer & Oncology Source Type: news

Mayo Clinic Minute: New smoking cessation study
If you're using the American Cancer Society's?Great American Smokeout?as part of an effort to quit smoking, join Drs.?J. Taylor Hays?and?David Midthun?on Friday, Nov. 17, from 2:30 to 3:30 p.m. CST, for a Facebook Live conversation?to discuss: Learn more about: Lung cancer screening Tobacco dependence treatments Smoking cessation A study on the effectiveness of increased communication [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 16, 2017 Category: Databases & Libraries Source Type: news

Charity appoints expert lung cancer nurse for North West
A new mesothelioma clinical nurse specialist has been appointed to support the high number of patients with the condition across Merseyside and Cheshire. (Source: Nursing Times)
Source: Nursing Times - November 15, 2017 Category: Nursing Source Type: news

Nodule count on CT not linked to lung cancer risk
Does a higher number of lung nodules detected on baseline CT screens indicate...Read more on AuntMinnie.comRelated Reading: New solid nodules may increase lung cancer risk Canadian risk model boosts CT lung screening efficiency Study: CT screening would cut lung cancer deaths in China Subsolid lung nodule assessment with CT evolves Results of European CT screening trial can be widely applied (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 14, 2017 Category: Radiology Source Type: news

Lung Cancer May Grow Faster During Immunotherapy Lung Cancer May Grow Faster During Immunotherapy
A retrospective analysis from France found that 14% of patients with advanced lung cancer showed an acceleration of tumor growth while receiving immunotherapy.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 13, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

NYPD Honors Flores for Work with Asbestos-Related Diseases
New York City Police Commissioner James O’Neill recently appointed mesothelioma specialist Dr. Raja Flores to the Society of Honorary Police Surgeons. The prestigious appointment stems from Flores’ continued, long-running service to so many first responders — particularly policemen and firemen from the 9/11 World Trade Center (WTC) terrorist attack in 2001. Although Flores has received many honors throughout his medical career, this one might be his most appreciated. “This is a huge honor for me,” Flores told Asbsetos.com. “I come from a family of cops. Police work is in my blood. My gra...
Source: Asbestos and Mesothelioma News - November 13, 2017 Category: Environmental Health Authors: Daniel King Tags: 9/11 9/11-related cancer James O’Neill Mount Sinai Hospital New York City Police Commissioner NYPD Raja Flores Society of Honorary Police Surgeons twin towers World Trade Center World Trade Center Health Program Source Type: news

#MayoClinicRadio podcast: 11/11/17
Listen: Mayo Clinic Radio 11/11/17 On the Mayo Clinic Radio podcast, Dr. David Midthun, a pulmonary and critical care physician at Mayo Clinic, and Dr. J. Taylor Hays, an internal medicine specialist at Mayo Clinic, explain how a new study?combines lung cancer screening with proactive referrals and increased communication to help people quit smoking.?Also on [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 13, 2017 Category: Databases & Libraries Source Type: news

FDA Cancer Drug Approvals in 2017
This slide show highlights some of this year ’s FDA approvals of cancer treatments, including new therapies and indications for breast cancer, lung cancer, and various blood cancers, as well as the first approval based not on disease site but by tumor marker. (Source: CancerNetwork)
Source: CancerNetwork - November 11, 2017 Category: Cancer & Oncology Authors: Cancer Network Editors Source Type: news

Chest doctors issue guidelines for CT lung cancer screening
An expert panel of chest physicians has updated its guidelines for low-dose...Read more on AuntMinnie.comRelated Reading: New solid nodules may increase lung cancer risk Canadian risk model boosts CT lung screening efficiency Study: CT screening would cut lung cancer deaths in China ARRS: Do NLST results translate to the real world? BMJ: Benefits of CT lung cancer screening outweigh dose (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 10, 2017 Category: Radiology Source Type: news

Voices: A Gay Husband, a Dire Diagnosis and the Best-Laid Plans
I was just as unprepared to hear my doctor say “ lung cancer ” as I had been to hear my husband say “ I ’ m gay. ” (Source: NYT Health)
Source: NYT Health - November 9, 2017 Category: Consumer Health News Authors: DANIELLE PERESS, M.D. Tags: Lung Cancer Homosexuality and Bisexuality Respiratory System Lungs Source Type: news

NCI awards $8M grant for AI in radiology/pathology
The U.S. National Cancer Institute (NCI) has awarded a five-year, $8 million...Read more on AuntMinnie.comRelated Reading: NIH opens massive x-ray database to propel AI research NIH releases massive database of chest x-rays NCI awards $17M grant for breast imaging How will AI affect radiology over the next 20 years? Moonshot group to award $1M for lung cancer detection (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 9, 2017 Category: Radiology Source Type: news

UK study shows cell signaling interaction may prevent key step in lung cancer progression
(University of Kentucky) New findings from University of Kentucky faculty published in Scientific Reports reveals a novel cell signaling interaction that may prevent a key step in lung cancer progression. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 9, 2017 Category: Cancer & Oncology Source Type: news

UCLA helps many to live long and prosper
In Westwood, more than 100 faculty experts from 25 departments have embarked on anall-encompassing push to cut the health and economic impacts of depression in half by the year 2050. The mammoth undertaking will rely on platforms developed by the new Institute for Precision Health, which will harness the power of big data and genomics to move toward individually tailored treatments and health-promotion strategies.On the same 419 acres of land, researchers across the spectrum, from the laboratory bench to the patient bedside, are ushering in a potentially game-changing approach to turning the body ’s immune defenses a...
Source: UCLA Newsroom: Health Sciences - November 9, 2017 Category: Universities & Medical Training Source Type: news

Zebra Medical Vision to host AI1 image analytics on Google Cloud
Israeli machine-learning radiology firm Zebra Medical Vision said it will be uploading its radiology algorithms to the Google (NSDQ:GOOG) Cloud as part of the AI1 automated imaging analytics tools offering it announced last month. The AI1 analytical platform includes a deep learning engine system that can detect various medical findings from image scans on its own, including the detection of liver, lung, cardiovascular and bone disease. The Israel-based company also said said it is planning to introduce new capabilities that would cover breast cancer, lung cancer, brain trauma, hypertension and oth...
Source: Mass Device - November 8, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Health Information Technology Imaging Zebra Medical Vision Source Type: news

Senate Introduces Latest Attempt to Ban Asbestos
U.S. Sen. Jeff Merkley, D-Ore., introduced legislation in Congress this week that would effectively ban all use of asbestos. The Alan Reinstein Ban Asbestos Now Act of 2017 is the sixth legislative attempt to ban the toxic substance in the last 20 years. All previous bills failed to gain enough support. While the 2016 Toxic Substances Control Act (TSCA) already includes asbestos on its top ten chemicals for risk review by the Environmental Protection Agency (EPA), Merkley’s legislation could speed the process considerably. What Would the Bill to Ban Asbestos Do? According to Merkley’s congressional office, the ...
Source: Asbestos and Mesothelioma News - November 8, 2017 Category: Environmental Health Authors: Daniel King Tags: Alan Reinstein Ban Asbestos Now Act asbestos ban Cory Booker environmental protection agency EPA Jeff Merkley Jon Tester Raja Flores Steve Daines Toxic Substances Control Act TSCA u.s. congress Source Type: news

Yoga May Give Lung Cancer Patients, Caregivers a Boost
Title: Yoga May Give Lung Cancer Patients, Caregivers a BoostCategory: Health NewsCreated: 11/7/2017 12:00:00 AMLast Editorial Review: 11/8/2017 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - November 8, 2017 Category: Cancer & Oncology Source Type: news

Chronic stress hormones may promote resistance to EGFR inhibitors in lung cancer patients
(University of Texas M. D. Anderson Cancer Center) Elevated levels of chronic stress hormones, such as those produced by psychological distress, may promote resistance to drugs commonly used to treat lung cancer patients with EGFR mutations, according to new research from The University of Texas MD Anderson Cancer Center. Retrospective analysis of clinical patient data suggests that beta blocker drugs may slow or prevent the development of resistance to EGFR inhibitors. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 8, 2017 Category: Cancer & Oncology Source Type: news

Kuni Foundation grants $7.5M to OHSU for lung and prostate cancer research
The Vancouver, Washington-based Wayne D. Kuni and Joan E. Kuni Foundation has given $7.5 million to Oregon Health& Science University to further cancer research. The foundation awarded $5 million for the OHSU Knight Cancer Institute to launch a lung cancer research center and gave $2.5 million for the creation of the Prostate Cancer Research endowed chair for Dr. Joshi Alumkal, an associate professor of medicine and former Kuni Scholar. “We are grateful for the innovative, life-saving work of… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 7, 2017 Category: Biotechnology Authors: Elizabeth Hayes Source Type: news

Kuni Foundation grants $7.5M to OHSU for lung and prostate cancer research
The Vancouver, Washington-based Wayne D. Kuni and Joan E. Kuni Foundation has given $7.5 million to Oregon Health& Science University to further cancer research. The foundation awarded $5 million for the OHSU Knight Cancer Institute to launch a lung cancer research center and gave $2.5 million for the creation of the Prostate Cancer Research endowed chair for Dr. Joshi Alumkal, an associate professor of medicine and former Kuni Scholar. “We are grateful for the innovative, life-saving work of… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - November 7, 2017 Category: American Health Authors: Elizabeth Hayes Source Type: news

Yoga May Boost Lung Cancer Patients, Caregivers
For advanced lung cancer patients, yoga appears to help improve their overall physical function, stamina and mental health. (Source: WebMD Health)
Source: WebMD Health - November 7, 2017 Category: Consumer Health News Source Type: news

Yoga May Give Lung Cancer Patients, Caregivers a Boost
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 7, 2017 Category: Cancer & Oncology Tags: Nursing, Oncology, Sports Medicine, News, Source Type: news

Yoga May Give Lung Cancer Patients, Caregivers a Boost
TUESDAY, Nov. 7, 2017 -- For advanced lung cancer patients, yoga appears to help improve their overall physical function, stamina and mental health. And it appears to give their caregivers a boost, as well. The findings stem from a small study of... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 7, 2017 Category: General Medicine Source Type: news

Pique Therapeutics Announces Positive Results in Phase 2 Clinical Trial of Lead Immunotherapy for Non-Small Cell Lung Cancer
PT 107 showed improvement in overall survival and significant improvement in time to progression, as compared to control In non-squamous patients, the benefit of PT 107 in overall survival was striking and highly significant PT 107 was well tolerated... Biopharmaceuticals, Oncology Pique Therapeutics, cell vaccine, lung cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 7, 2017 Category: Pharmaceuticals Source Type: news

New solid nodules may increase lung cancer risk
Lung nodules found on follow-up CT lung screening rounds could be more dangerous...Read more on AuntMinnie.comRelated Reading: Canadian risk model boosts CT lung screening efficiency Subsolid lung nodule assessment with CT evolves ARRS: Do NLST results translate to the real world? Cost-effectiveness, implementation still hinder lung cancer screening BMJ: Benefits of CT lung cancer screening outweigh dose (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 7, 2017 Category: Radiology Source Type: news

FDA approves Roche ’s Alecensa (alectinib) as first-line treatment for people with specific type of lung cancer
Roche today announced that the US Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for Alecensa ® (alectinib) for the treatment of people with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test. (Source: Roche Media News)
Source: Roche Media News - November 7, 2017 Category: Pharmaceuticals Source Type: news

FDA approves Roche ’s Alecensa (alectinib) as first-line treatment for people with specific type of lung cancer
Roche today announced that the US Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for Alecensa ® (alectinib) for the treatment of people with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test. (Source: Roche Investor Update)
Source: Roche Investor Update - November 7, 2017 Category: Pharmaceuticals Source Type: news

BU researcher leads team in 'cancer interception' project
(Boston University School of Medicine) Developing diagnostic tools to 'intercept' lung cancer at its earliest stage is the goal of a research team led by Boston University School of Medicine (BUSM), along with colleagues at the University of California, Los Angeles (UCLA). Using innovative approaches such as nasal swabs, blood tests and radiological imaging, scientists look to confirm whether lung abnormalities found on chest imaging are benign lung disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 7, 2017 Category: Cancer & Oncology Source Type: news

Yoga May Give Lung Cancer Patients, Caregivers a Boost
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - November 7, 2017 Category: Cancer & Oncology Source Type: news

FDA approves Roche drugs for rare types of blood, lung cancers
(Reuters) - Roche Holding AG won U.S. approval to market its skin cancer drug Zelboraf for certain patients with Erdheim-Chester Disease, a rare type of blood cancer, and to market its drug Alecensa as a first choice of treatment for a subset of patients with non-small cell lung cancer. (Source: Reuters: Health)
Source: Reuters: Health - November 6, 2017 Category: Consumer Health News Tags: healthNews Source Type: news